Company intelligence / Profile preview

Rewire AI

Portland, Oregon, United Statesrewire.ai ↗

Ownership: Private
Employees: ~10
Development stage: Commercial

Overview

Rewire AI provides commercialized artificial intelligence solutions for automated detection and quantification of biomarkers in biomedical images. Their platforms are used globally by over 2,500 researchers with more than 60 published papers citing their technology. The company claims significant improvements in data accuracy (+96%), speed (-99% time), and cost savings (-80%) compared to manual methods.

Therapeutic areas: Other
Modalities: Not directly therapeutic; focuses on digital/AI modalities for biomedical image analysis (e.g., cell detection, biomarker quantification)
Industry: Pathology

Partnerships

Neurescence Inc. (neuronal segmentation/calcium imaging partnership)Eppendorf Group’s eLabNext (platform integration partnership)

Beyond the preview

Go deeper on Rewire AI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rewire AI.

Explore the full profile